LabCentral co-founder issues ‘call to action’ to biotechs on drug pricing

LabCentral co-founder and industry veteran Johannes Fruehauf is calling for startups and small biotechs to get off the lab bench and get involved in the drug pricing conversation. “This is a call to action…. Hopefully, my speaking up will help others to reflect on what role they play in this continuum," he said.